IRAK1/4 inhibitor I, IRAK1 shRNA, and IRAK4 shRNA show antiproliferative effects on T-ALL cells through a mechanism involving destabilization of the anti-apoptotic protein-induced myeloid leukemia cell differentiation protein 1 (MCL-1) [224]. This evidence concerns the gene MCL1 and acute lymphoblastic leukemia.